Stay updated on Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page.

Latest updates to the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History, and the v3.3.3 entry was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdds a new revision entry 'Revision: v3.3.3' to the history. Removes the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry from the footer.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page history shows a new version entry (v3.3.2) and the previous version (v3.3.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history shows a new revision v3.3.1 added and revision v3.2.0 removed, which are minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe government funding status notice about operating status at the bottom of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check82 days agoChange DetectedVersion history shows updates to Recruitment Status and Study Status across versions 2 and 3. Version 4 adds or updates multiple sections including Study Identification, IPDSharing, Outcome Measures, and Adverse Events.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page.